Pitavastatin, launched for the treatment of hypercholesterolemia, belongs to the family of second-generation statins, also referred to as superstatins due to their improved efficacy as cholesterol lowering agents. Like other statins, pitavastatin reduces plasma cholesterol levels by competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis in the liver
Pitavastatin calcium is a potent synthetic HMG-CoA reductase inhibitor used in lipid management. Produced via advanced chiral synthesis, its molecular formula is C24H26CaF2N2O5 with CAS 170638-90-1.
Contraindicated in active liver disease or pregnancy. Store API in a cool, dry place below 25°C to prevent hydrolysis. Strict adherence to GMP guidelines is required during handling to ensure patient safety.